Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07283718
What this trial is testing

The Association Between Axillary Lymph Node Metastasis Patterns and Breast Cancer Prognosis

Who this might be right for
Breast Cancer Invasive
Wenjin Yin 2,467
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07591597
What this trial is testing

A Multicenter, Phase Ib/II Clinical Trial to Evaluate the Efficacy and Safety of Concurrent Combination Therapy of S-531011 Plus Fruquintinib or S-531011 Plus Fruquintinib Plus Pembrolizumab in Patients With MSS/pMMR Colorectal Cancer

Who this might be right for
Metastatic Colorectal NeoplasmsMicrosatellite Stable / Proficient Mismatch Repair Colorectal Cancer
National Cancer Center Hospital East 68
Not applicableStudy completedNCT02201797
What this trial is testing

Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body

Who this might be right for
Metastatic Liver Cancer
Asan Medical Center 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06788197
What this trial is testing

SHR-A1811 and Fulvestrant, With or Without HS-10352, in Locally Advanced or Metastatic Breast Cancer Patients

Who this might be right for
Breast CancerLocally Advanced or Metastatic Breast Cancer
Henan Cancer Hospital 52
Testing effectiveness (Phase 2)Looking for participantsNCT07789210
What this trial is testing

A Single-Arm, Phase II, Multicenter Clinical Study of Neoadjuvant Encorafenib Plus Cetuximab N01 and mFOLFOX6 in Patients With Locally Advanced BRAF V600E-Mutant Colorectal Cancer With or Without Resectable Metastases

Who this might be right for
Colorectal CancerBRAF V600E Mutation PositiveEncorafenib+1 more
Zhejiang University 25
Testing effectiveness (Phase 2)Study completedNCT00059813
What this trial is testing

Oblimersen and Interferon Alfa in Treating Patients With Metastatic Renal Cell Cancer

Who this might be right for
Recurrent Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)UnknownNCT04102982
What this trial is testing

Microwave Ablation in Combination With Camrelizumab Versus Camrelizumab in Metastatic Non-small-cell Lung Cancer

Who this might be right for
NSCLC Stage IV
Shandong Provincial Hospital 200
Not applicableLooking for participantsNCT07584824
What this trial is testing

Is the 1939 Cancer Act Fit for Purpose in the Modern Technology Era?

Who this might be right for
CancerCancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment/Care Regimen; i.e. Curative, Life-extending, or PalliativeCancer (Solid Tumors)+2 more
Royal Cornwall Hospitals Trust 50
Not applicableLooking for participantsNCT00242723
What this trial is testing

Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining

Who this might be right for
Thoracic CancersMalignant Pleural Mesotheliomas NOSLung Cancer NOS+3 more
National Cancer Institute (NCI) 1,559
Early research (Phase 1)Study completedNCT01928459
What this trial is testing

Phase 1b Trial of BGJ398/BYL719 in Solid Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Solid Tumors
Novartis Pharmaceuticals 62
Not applicableEnded earlyNCT03057743
What this trial is testing

Imaging of in Vivo Sigma-2 Receptor Expression With 18F-ISO-1 Positron Emission Tomography in Metastatic Breast Cancer

Who this might be right for
METASTATIC BREAST CANCER
Abramson Cancer Center at Penn Medicine 4
Testing effectiveness (Phase 2)Study completedNCT00178243
What this trial is testing

Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation

Who this might be right for
Liver NeoplasmsNeoplasm Metastasis
University of Rochester
Not applicableWithdrawnNCT05222308
What this trial is testing

Advanced Planning for Online Accounts and Data

Who this might be right for
Terminal CancerMetastatic Cancer
University of Colorado, Denver
Early research (Phase 1)Study completedNCT00037817
What this trial is testing

Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies

Who this might be right for
Advanced Esophageal CancersPrimary Small Cell Lung CancersNon-Small-Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Study completedNCT00492817
What this trial is testing

Evaluation of Single Session Stereotactic Body Radiotherapy

Who this might be right for
Spinal Neoplasms
M.D. Anderson Cancer Center 71
Not applicableEnded earlyNCT00608517
What this trial is testing

Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Vanderbilt-Ingram Cancer Center 6
Early research (Phase 1)WithdrawnNCT02396368
What this trial is testing

Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate CancerBone-only Metastatic Castration-Resistant Prostate Cancer (CRPC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Ended earlyNCT03391050
What this trial is testing

APR-246 in Combination With Dabrafenib in Resistant Patients With BRAF V600 Mutant Melanoma

Who this might be right for
Melanoma
Aprea Therapeutics 3
Testing effectiveness (Phase 2)WithdrawnNCT04265274
What this trial is testing

Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.

Who this might be right for
Metastatic Breast Cancer
National Cancer Institute, Slovakia
Testing effectiveness (Phase 2)Study completedNCT01328574
What this trial is testing

TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma

Who this might be right for
Urothelial CarcinomaUreteral NeoplasmsUreter Cancer+2 more
National Cancer Institute (NCI) 13
Next Page